Actimed Therapeutics Ltd.

Having got the thumbs-up from the US Food and Drug Administration to start late-stage trials of its cancer cachexia treatment, Actimed Therapeutics Ltd. is now focusing on raising the necessary fund

Venture capital funding for biopharmaceutical companies overall may be down in 2023, but that does not mean that investors have stopped placing big bets on the industry. Three companies announced rece

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Gain, Zentalis Hope To Find Protein Mis